Log In
BCIQ
Print this Print this
 

TAK-799, TRM-1

  Manage Alerts
Collapse Summary General Information
Company GlaxoSmithKline plc
DescriptionTRAIL receptor-1 human mAb (TRAIL-R1 mAb)
Molecular Target Tumor necrosis factor (TNF) receptor superfamily member 10a (TNFRSF10A) (DR4) (TRAILR1) (CD261)
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPreclinical
Standard IndicationSolid tumors
Indication DetailsTreat solid tumors
Regulatory Designation
PartnerTakeda Pharmaceutical Co. Ltd.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today